<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34199367</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>02</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Mechanisms of TDP-43 Proteinopathy Onset and Propagation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6004</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22116004</ELocationID><Abstract><AbstractText>TDP-43 is an RNA-binding protein that has been robustly linked to the pathogenesis of a number of neurodegenerative disorders, including amyotrophic lateral sclerosis and frontotemporal dementia. While mutations in the TARDBP gene that codes for the protein have been identified as causing disease in a small subset of patients, TDP-43 proteinopathy is present in the majority of cases regardless of mutation status. This raises key questions regarding the mechanisms by which TDP-43 proteinopathy arises and spreads throughout the central nervous system. Numerous studies have explored the role of a variety of cellular functions on the disease process, and nucleocytoplasmic transport, protein homeostasis, RNA interactions and cellular stress have all risen to the forefront as possible contributors to the initiation of TDP-43 pathogenesis. There is also a small but growing body of evidence suggesting that aggregation-prone TDP-43 can recruit physiological TDP-43, and be transmitted intercellularly, providing a mechanism whereby small-scale proteinopathy spreads from cell to cell, reflecting the spread of clinical symptoms observed in patients. This review will discuss the potential role of the aforementioned cellular functions in TDP-43 pathogenesis, and explore how aberrant pathology may spread, and result in a feed-forward cascade effect, leading to robust TDP-43 proteinopathy and disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Han-Jou</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0001-7875-8661</Identifier><AffiliationInfo><Affiliation>Department of Biology, York Biomedical Research Institute, University of York, Wentworth Way, York YO10 5DD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Jacqueline C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-2677-398X</Identifier><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 125 Coldharbour Lane, Camberwell, London SE5 9NU, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Chen/Apr17/858-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>Mitchell/Apr14/828-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>(internal funding)</GrantID><Agency>KCL Van Geest foundation fellowship</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="N">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">proteinopathy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34199367</ArticleId><ArticleId IdType="pmc">PMC8199531</ArticleId><ArticleId IdType="doi">10.3390/ijms22116004</ArticleId><ArticleId IdType="pii">ijms22116004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nussbacher J.K., Tabet R., Yeo G.W., Lagier-Tourenne C. Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions. Neuron. 2019;102:294&#x2013;320. doi: 10.1016/j.neuron.2019.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.03.014</ArticleId><ArticleId IdType="pmc">PMC6545120</ArticleId><ArticleId IdType="pubmed">30998900</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Amador-Ortiz C., Lin W.L., Ahmed Z., Personett D., Davies P., Duara R., Graff-Radford N.R., Hutton M.L., Dickson D.W. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer&#x2019;s disease. Ann. Neurol. 2007;61:435&#x2013;445. doi: 10.1002/ana.21154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21154</ArticleId><ArticleId IdType="pmc">PMC2677204</ArticleId><ArticleId IdType="pubmed">17469117</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.K., Spiller K.J., Ge G., Zheng A., Xu Y., Zhou M., Tripathy K., Kwong L.K., Trojanowski J.Q., Lee V.M. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015;130:643&#x2013;660. doi: 10.1007/s00401-015-1460-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1460-x</ArticleId><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.J., Mitchell J.C., Novoselov S., Miller J., Nishimura A.L., Scotter E.L., Vance C.A., Cheetham M.E., Shaw C.E. The heat shock response plays an important role in TDP-43 clearance: Evidence for dysfunction in amyotrophic lateral sclerosis. Brain. 2016;139:1417&#x2013;1432. doi: 10.1093/brain/aww028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww028</ArticleId><ArticleId IdType="pmc">PMC4845254</ArticleId><ArticleId IdType="pubmed">26936937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou S.H., Wu F., Harrich D., Garcia-Martinez L.F., Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 1995;69:3584&#x2013;3596. doi: 10.1128/jvi.69.6.3584-3596.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.6.3584-3596.1995</ArticleId><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Y.M., Zago P., D&#x2019;Ambrogio A., Xu Y.F., Petrucelli L., Buratti E., Baralle F.E. Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 2008;121:3778&#x2013;3785. doi: 10.1242/jcs.038950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.038950</ArticleId><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey J.R., Curk T., Rogelj B., Briese M., Cereda M., Kayikci M., Konig J., Hortobagyi T., Nishimura A.L., Zupunski V., et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 2011;14:452&#x2013;458. doi: 10.1038/nn.2778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Onesto E., Megiorni F., Pizzuti A., Baralle F.E., Buratti E., Silani V., Ratti A. TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J. Biol. Chem. 2012;287:15635&#x2013;15647. doi: 10.1074/jbc.M111.333450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.333450</ArticleId><ArticleId IdType="pmc">PMC3346140</ArticleId><ArticleId IdType="pubmed">22427648</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro A., Kimura N., Watanabe Y., Watanabe S., Ishihama A. TDP-43 binds and transports G-quadruplex-containing mRNAs into neurites for local translation. Genes Cells. 2016;21:466&#x2013;481. doi: 10.1111/gtc.12352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12352</ArticleId><ArticleId IdType="pubmed">26915990</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano S., Jinno J., Abdelhamid R.F., Jin Y., Shibata M., Watanabe S., Hirokawa S., Nishizawa M., Sakimura K., Onodera O., et al. TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons. Acta Neuropathol. 2020;140:695&#x2013;713. doi: 10.1007/s00401-020-02205-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02205-y</ArticleId><ArticleId IdType="pubmed">32803350</ArticleId></ArticleIdList></Reference><Reference><Citation>Loganathan S., Lehmkuhl E.M., Eck R.J., Zarnescu D.C. To Be or Not To Be&#x2026;Toxic-Is RNA Association With TDP-43 Complexes Deleterious or Protective in Neurodegeneration? Front. Mol. Biosci. 2019;6:154. doi: 10.3389/fmolb.2019.00154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2019.00154</ArticleId><ArticleId IdType="pmc">PMC6965497</ArticleId><ArticleId IdType="pubmed">31998750</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer B.C., Schuck T., Wheeler J.M., Robinson L.C., Trojanowski J.Q., Lee V.M., Schellenberg G.D. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol. 2010;119:409&#x2013;419. doi: 10.1007/s00401-010-0659-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0659-0</ArticleId><ArticleId IdType="pmc">PMC2880609</ArticleId><ArticleId IdType="pubmed">20198480</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., Kwong L.K., Forman M.S., Ravits J., Stewart H., et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 2007;61:427&#x2013;434. doi: 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair I.P., Williams K.L., Warraich S.T., Durnall J.C., Thoeng A.D., Manavis J., Blumbergs P.C., Vucic S., Kiernan M.C., Nicholson G.A. FUS mutations in amyotrophic lateral sclerosis: Clinical, pathological, neurophysiological and genetic analysis. J. Neurol. Neurosurg. Psychiatry. 2010;81:639&#x2013;645. doi: 10.1136/jnnp.2009.194399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.194399</ArticleId><ArticleId IdType="pubmed">19965854</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Zupunski V., Troakes C., Kathe C., Fratta P., Howell M., Gallo J.M., Hortobagyi T., Shaw C.E., Rogelj B. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain. 2010;133:1763&#x2013;1771. doi: 10.1093/brain/awq111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq111</ArticleId><ArticleId IdType="pubmed">20472655</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinarbasi E.S., Cagatay T., Fung H.Y.J., Li Y.C., Chook Y.M., Thomas P.J. Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization. Sci. Rep. 2018;8:7083. doi: 10.1038/s41598-018-25008-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25008-4</ArticleId><ArticleId IdType="pmc">PMC5935693</ArticleId><ArticleId IdType="pubmed">29728608</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold H.C., Jackson K.L., Arora A., Weskamp K., Tank E.M., Li X., Miguez R., Dayton R.D., Tamir S., Klein R.L., et al. TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci. Rep. 2018;8:4606. doi: 10.1038/s41598-018-22858-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22858-w</ArticleId><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H., Funk C., Abou-Ajram C., Hutten S., Funk E.B.E., Kehlenbach R.H., Bailer S.M., Dormann D. Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1/CRM1. Sci. Rep. 2018;8:7084. doi: 10.1038/s41598-018-25007-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25007-5</ArticleId><ArticleId IdType="pmc">PMC5935713</ArticleId><ArticleId IdType="pubmed">29728564</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Skibinski G., Korb E., Rao E.J., Wu J.Y., Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J. Neurosci. 2010;30:639&#x2013;649. doi: 10.1523/JNEUROSCI.4988-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4988-09.2010</ArticleId><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutihac R., Alegre-Abarrategui J., Gordon D., Farrimond L., Yamasaki-Mann M., Talbot K., Wade-Martins R. TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca2+ signaling in motor neurons. Neurobiol. Dis. 2015;75:64&#x2013;77. doi: 10.1016/j.nbd.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.010</ArticleId><ArticleId IdType="pubmed">25526708</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsuzawa S., Akiyama T., Nishiyama A., Suzuki N., Kato M., Warita H., Izumi R., Osana S., Koyama S., Kato T., et al. TARDBP p.G376D mutation, found in rapid progressive familial ALS, induces mislocalization of TDP-43. Eneurologicalsci. 2018;11:20&#x2013;22. doi: 10.1016/j.ensci.2018.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2018.04.001</ArticleId><ArticleId IdType="pmc">PMC6006914</ArticleId><ArticleId IdType="pubmed">29928714</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.C., Zhang Y., Umoh M.E., Vaughan S.W., Lorenzini I., Liu F., Sayegh M., Donlin-Asp P.G., Chen Y.H., Duong D.M., et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui K., Huang Y. RanGTPase: A Key Regulator of Nucleocytoplasmic Trafficking. Mol. Cell Pharmacol. 2009;1:148&#x2013;156. doi: 10.4255/mcpharmacol.09.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.4255/mcpharmacol.09.19</ArticleId><ArticleId IdType="pmc">PMC2839366</ArticleId><ArticleId IdType="pubmed">20300488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward M.E., Taubes A., Chen R., Miller B.L., Sephton C.F., Gelfand J.M., Minami S., Boscardin J., Martens L.H., Seeley W.W., et al. Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. J. Exp. Med. 2014;211:1937&#x2013;1945. doi: 10.1084/jem.20140214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20140214</ArticleId><ArticleId IdType="pmc">PMC4172214</ArticleId><ArticleId IdType="pubmed">25155018</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F., Lu S., Yu H., Chen C., Melamed Z., Guo L., Shorter J., Da Cruz S., Cleveland D.W. Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death. Neuron. 2019;102:339&#x2013;357.e7. doi: 10.1016/j.neuron.2019.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.038</ArticleId><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton M.J., Igaz L.M., Wong M.M., Kwong L.K., Trojanowski J.Q., Lee V.M. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 2008;283:13302&#x2013;13309. doi: 10.1074/jbc.M800342200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800342200</ArticleId><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Duan Y., Duan G., Wang Q., Zhang K., Deng X., Qian B., Gu J., Ma Z., Zhang S., et al. Stress Induces Dynamic, Cytotoxicity-Antagonizing TDP-43 Nuclear Bodies via Paraspeckle LncRNA NEAT1-Mediated Liquid-Liquid Phase Separation. Mol. Cell. 2020;79:443&#x2013;458.e7. doi: 10.1016/j.molcel.2020.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.06.019</ArticleId><ArticleId IdType="pubmed">32649883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Y.M., De Conti L., Avendano-Vazquez S.E., Dhir A., Romano M., D&#x2019;Ambrogio A., Tollervey J., Ule J., Baralle M., Buratti E., et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2011;30:277&#x2013;288. doi: 10.1038/emboj.2010.310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.310</ArticleId><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Avendano-Vazquez S.E., Dhir A., Bembich S., Buratti E., Proudfoot N., Baralle F.E. Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev. 2012;26:1679&#x2013;1684. doi: 10.1101/gad.194829.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.194829.112</ArticleId><ArticleId IdType="pmc">PMC3418585</ArticleId><ArticleId IdType="pubmed">22855830</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Chen Y., Zhou X., Kar A., Ray P., Chen X., Rao E.J., Yang M., Ye H., Zhu L., et al. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat. Struct. Mol. Biol. 2011;18:822&#x2013;830. doi: 10.1038/nsmb.2053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2053</ArticleId><ArticleId IdType="pmc">PMC3357956</ArticleId><ArticleId IdType="pubmed">21666678</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Kaneko K., Yamanaka K. Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins. J. Biol. Chem. 2013;288:3641&#x2013;3654. doi: 10.1074/jbc.M112.433615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.433615</ArticleId><ArticleId IdType="pmc">PMC3561582</ArticleId><ArticleId IdType="pubmed">23235148</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin J.A., Wright G.S., Watanabe S., Grossmann J.G., Antonyuk S.V., Yamanaka K., Hasnain S.S. Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life. Proc. Natl. Acad. Sci. USA. 2014;111:4309&#x2013;4314. doi: 10.1073/pnas.1317317111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1317317111</ArticleId><ArticleId IdType="pmc">PMC3964094</ArticleId><ArticleId IdType="pubmed">24591609</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J.C., Constable R., So E., Vance C., Scotter E., Glover L., Hortobagyi T., Arnold E.S., Ling S.C., McAlonis M., et al. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. Acta Neuropathol. Commun. 2015;3:36. doi: 10.1186/s40478-015-0212-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0212-4</ArticleId><ArticleId IdType="pmc">PMC4479086</ArticleId><ArticleId IdType="pubmed">26108367</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanznaster D., Bourgeais J., Bruno C., Hergesheimer R.C., Thepault R.A., Vourc&#x2019;h P., Corcia P., Andres C.R., Herault O., Blasco H. TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis. Cells. 2019;9:68. doi: 10.3390/cells9010068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9010068</ArticleId><ArticleId IdType="pmc">PMC7016571</ArticleId><ArticleId IdType="pubmed">31888078</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E., Kuiperij H.B., van Blitterswijk M.M., Veldink J.H., Schelhaas H.J., van den Berg L.H., Verbeek M.M. TDP-43 plasma levels are higher in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2012;13:446&#x2013;451. doi: 10.3109/17482968.2012.703208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.703208</ArticleId><ArticleId IdType="pubmed">22873561</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder V., Gregory J.M., Barria M.A., Green A., Pal S. TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: A systematic review and meta-analysis. BMC Neurol. 2018;18:90. doi: 10.1186/s12883-018-1091-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-018-1091-7</ArticleId><ArticleId IdType="pmc">PMC6027783</ArticleId><ArticleId IdType="pubmed">29954341</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Halliday G.M., Kiernan M.C., Tan R.H. TDP-43 levels in the brain tissue of ALS cases with and without C9ORF72 or ATXN2 gene expansions. Neurology. 2019;93:e1748&#x2013;e1755. doi: 10.1212/WNL.0000000000008439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008439</ArticleId><ArticleId IdType="pubmed">31619481</ArticleId></ArticleIdList></Reference><Reference><Citation>Hishizawa M., Yamashita H., Akizuki M., Urushitani M., Takahashi R. TDP-43 levels are higher in platelets from patients with sporadic amyotrophic lateral sclerosis than in healthy controls. Neurochem. Int. 2019;124:41&#x2013;45. doi: 10.1016/j.neuint.2018.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2018.12.009</ArticleId><ArticleId IdType="pubmed">30578840</ArticleId></ArticleIdList></Reference><Reference><Citation>Udan-Johns M., Bengoechea R., Bell S., Shao J., Diamond M.I., True H.L., Weihl C.C., Baloh R.H. Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones. Hum. Mol. Genet. 2014;23:157&#x2013;170. doi: 10.1093/hmg/ddt408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt408</ArticleId><ArticleId IdType="pmc">PMC3857952</ArticleId><ArticleId IdType="pubmed">23962724</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P.Y., Folorunso O., Taglialatela G., Pierce A. Overexpression of heat shock factor 1 maintains TAR DNA binding protein 43 solubility via induction of inducible heat shock protein 70 in cultured cells. J. Neurosci. Res. 2016;94:671&#x2013;682. doi: 10.1002/jnr.23725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23725</ArticleId><ArticleId IdType="pubmed">26994698</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Vance C., Nishimura A.L., Lee Y.B., Chen H.J., Urwin H., Sardone V., Mitchell J.C., Rogelj B., Rubinsztein D.C., et al. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J. Cell Sci. 2014;127:1263&#x2013;1278. doi: 10.1242/jcs.140087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.140087</ArticleId><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V., Cicardi M.E., Ramesh N., Seguin S.J., Ganassi M., Bigi I., Diacci C., Zelotti E., Baratashvili M., Gregory J.M., et al. The chaperone HSPB8 reduces the accumulation of truncated TDP-43 species in cells and protects against TDP-43-mediated toxicity. Hum. Mol. Genet. 2016;25:3908&#x2013;3924. doi: 10.1093/hmg/ddw232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw232</ArticleId><ArticleId IdType="pmc">PMC5291228</ArticleId><ArticleId IdType="pubmed">27466192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella R., Fani G., Capitini C., Rusmini P., Poletti A., Cecchi C., Chiti F. Quantitative assessment of the degradation of aggregated TDP-43 mediated by the ubiquitin proteasome system and macroautophagy. FASEB J. 2017;31:5609&#x2013;5624. doi: 10.1096/fj.201700292RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700292RR</ArticleId><ArticleId IdType="pubmed">28842427</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M.E., Cristofani R., Rusmini P., Meroni M., Ferrari V., Vezzoli G., Tedesco B., Piccolella M., Messi E., Galbiati M., et al. Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells. Sci. Rep. 2018;8:12390. doi: 10.1038/s41598-018-29658-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-29658-2</ArticleId><ArticleId IdType="pmc">PMC6098007</ArticleId><ArticleId IdType="pubmed">30120266</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F., Miki Y., Kon T., Tanji K., Wakabayashi K. Autophagy Is a Common Degradation Pathway for Bunina Bodies and TDP-43 Inclusions in Amyotrophic Lateral Sclerosis. J. Neuropathol. Exp. Neurol. 2019;78:910&#x2013;921. doi: 10.1093/jnen/nlz072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlz072</ArticleId><ArticleId IdType="pubmed">31504678</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., Byrd A., Warner A.N., Pei F., Basha E., Buchanan A., Buchan J.R. Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover. Mol. Cell Biol. 2020;40 doi: 10.1128/MCB.00256-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00256-19</ArticleId><ArticleId IdType="pmc">PMC6996276</ArticleId><ArticleId IdType="pubmed">31767634</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormeno F., Hormazabal J., Moreno J., Riquelme F., Rios J., Criollo A., Albornoz A., Alfaro I.E., Budini M. Chaperone Mediated Autophagy Degrades TDP-43 Protein and Is Affected by TDP-43 Aggregation. Front. Mol. Neurosci. 2020;13:19. doi: 10.3389/fnmol.2020.00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00019</ArticleId><ArticleId IdType="pmc">PMC7040037</ArticleId><ArticleId IdType="pubmed">32132902</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I.F., Guo B.S., Liu Y.C., Wu C.C., Yang C.H., Tsai K.J., Shen C.K. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl. Acad. Sci. USA. 2012;109:15024&#x2013;15029. doi: 10.1073/pnas.1206362109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206362109</ArticleId><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C.W., Lin M.J., Shen C.K. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP. J. Neurogenet. 2015;29:59&#x2013;68. doi: 10.3109/01677063.2015.1077832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01677063.2015.1077832</ArticleId><ArticleId IdType="pubmed">26219309</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., Coyne A.N., Pei F., Vaughan S., Chaung M., Zarnescu D.C., Buchan J.R. Endocytosis regulates TDP-43 toxicity and turnover. Nat. Commun. 2017;8:2092. doi: 10.1038/s41467-017-02017-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02017-x</ArticleId><ArticleId IdType="pmc">PMC5727062</ArticleId><ArticleId IdType="pubmed">29233983</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibiger C., Deisel J., Aufschnaiter A., Ambros S., Tereshchenko M., Verheijen B.M., Buttner S., Braun R.J. TDP-43 controls lysosomal pathways thereby determining its own clearance and cytotoxicity. Hum. Mol. Genet. 2018;27:1593&#x2013;1607. doi: 10.1093/hmg/ddy066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy066</ArticleId><ArticleId IdType="pubmed">29474575</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamaki Y., Shodai A., Morimura T., Hikiami R., Minamiyama S., Ayaki T., Tooyama I., Furukawa Y., Takahashi R., Urushitani M. Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals. Sci. Rep. 2018;8:6030. doi: 10.1038/s41598-018-24463-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-24463-3</ArticleId><ArticleId IdType="pmc">PMC5902603</ArticleId><ArticleId IdType="pubmed">29662239</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F., Yan J., Vemula S.P., Liu E., Yang Y., Chen W., Zheng J.G., Shi Y., Siddique N., Arrat H., et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 2011;68:1440&#x2013;1446. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.F., Wang Q., Krueger B.J., et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., Muller K., Marroquin N., Nordin F., Hubers A., Weydt P., et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilli M., Arko-Mensah J., Ponpuak M., Roberts E., Master S., Mandell M.A., Dupont N., Ornatowski W., Jiang S., Bradfute S.B., et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity. 2012;37:223&#x2013;234. doi: 10.1016/j.immuni.2012.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.04.015</ArticleId><ArticleId IdType="pmc">PMC3428731</ArticleId><ArticleId IdType="pubmed">22921120</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai R.M., Li C.C. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat. Cell Biol. 2001;3:740&#x2013;744. doi: 10.1038/35087056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35087056</ArticleId><ArticleId IdType="pubmed">11483959</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R., Bett J.S., Keuss M.J., Solovyova A., McWilliams T.G., Johnson C., Sahu I., Varghese J., Wood N., Wightman M., et al. UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. Cell. 2016;166:935&#x2013;949. doi: 10.1016/j.cell.2016.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.07.001</ArticleId><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi H., Shoji K., Kiyokawa K., Negishi L., Tomari Y. VCP Machinery Mediates Autophagic Degradation of Empty Argonaute. Cell Rep. 2019;28:1144&#x2013;1153.e4. doi: 10.1016/j.celrep.2019.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.07.003</ArticleId><ArticleId IdType="pubmed">31365860</ArticleId></ArticleIdList></Reference><Reference><Citation>Batulan Z., Shinder G.A., Minotti S., He B.P., Doroudchi M.M., Nalbantoglu J., Strong M.J., Durham H.D. High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1. J. Neurosci. 2003;23:5789&#x2013;5798. doi: 10.1523/JNEUROSCI.23-13-05789.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-13-05789.2003</ArticleId><ArticleId IdType="pmc">PMC6741252</ArticleId><ArticleId IdType="pubmed">12843283</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelin E., Freeman B.C. Lysine deacetylases regulate the heat shock response including the age-associated impairment of HSF1. J. Mol. Biol. 2015;427:1644&#x2013;1654. doi: 10.1016/j.jmb.2015.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2015.02.010</ArticleId><ArticleId IdType="pmc">PMC4357550</ArticleId><ArticleId IdType="pubmed">25688804</ArticleId></ArticleIdList></Reference><Reference><Citation>Brehme M., Voisine C., Rolland T., Wachi S., Soper J.H., Zhu Y., Orton K., Villella A., Garza D., Vidal M., et al. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease. Cell Rep. 2014;9:1135&#x2013;1150. doi: 10.1016/j.celrep.2014.09.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.09.042</ArticleId><ArticleId IdType="pmc">PMC4255334</ArticleId><ArticleId IdType="pubmed">25437566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ori A., Toyama B.H., Harris M.S., Bock T., Iskar M., Bork P., Ingolia N.T., Hetzer M.W., Beck M. Integrated Transcriptome and Proteome Analyses Reveal Organ-Specific Proteome Deterioration in Old Rats. Cell Syst. 2015;1:224&#x2013;237. doi: 10.1016/j.cels.2015.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2015.08.012</ArticleId><ArticleId IdType="pmc">PMC4802414</ArticleId><ArticleId IdType="pubmed">27135913</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelmer Sacramento E., Kirkpatrick J.M., Mazzetto M., Baumgart M., Bartolome A., Di Sanzo S., Caterino C., Sanguanini M., Papaevgeniou N., Lefaki M., et al. Reduced proteasome activity in the aging brain results in ribosome stoichiometry loss and aggregation. Mol. Syst. Biol. 2020;16:e9596. doi: 10.15252/msb.20209596.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209596</ArticleId><ArticleId IdType="pmc">PMC7301280</ArticleId><ArticleId IdType="pubmed">32558274</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.I., Han K.S., Kim C.W., Ryu K.S., Kim B.H., Kim K.H., Kim S.I., Kang T.H., Shin H.C., Lim K.H., et al. Protein solubility and folding enhancement by interaction with RNA. PLoS ONE. 2008;3:e2677. doi: 10.1371/journal.pone.0002677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002677</ArticleId><ArticleId IdType="pmc">PMC2444022</ArticleId><ArticleId IdType="pubmed">18628952</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.C., Lin K.F., He R.Y., Tu P.H., Koubek J., Hsu Y.C., Huang J.J. Inhibition of TDP-43 aggregation by nucleic acid binding. PLoS ONE. 2013;8:e64002. doi: 10.1371/journal.pone.0064002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064002</ArticleId><ArticleId IdType="pmc">PMC3667863</ArticleId><ArticleId IdType="pubmed">23737961</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Arslan P.E., Won A., Yip C.M., Chakrabartty A. Binding of TDP-43 to the 3&#x2019;UTR of its cognate mRNA enhances its solubility. Biochemistry. 2014;53:5885&#x2013;5894. doi: 10.1021/bi500617x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi500617x</ArticleId><ArticleId IdType="pubmed">25171271</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.J., Topp S.D., Hui H.S., Zacco E., Katarya M., McLoughlin C., King A., Smith B.N., Troakes C., Pastore A., et al. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy. Brain. 2019;142:3753&#x2013;3770. doi: 10.1093/brain/awz313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz313</ArticleId><ArticleId IdType="pmc">PMC6885686</ArticleId><ArticleId IdType="pubmed">31605140</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann J.R., Gleixner A.M., Mauna J.C., Gomes E., DeChellis-Marks M.R., Needham P.G., Copley K.E., Hurtle B., Portz B., Pyles N.J., et al. RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Neuron. 2019;102:321&#x2013;338e. doi: 10.1016/j.neuron.2019.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S., Jain M., Yang W.Z., Yuan H.S. Frontotemporal dementia-linked P112H mutation of TDP-43 induces protein structural change and impairs its RNA binding function. Protein Sci. 2021;30:350&#x2013;365. doi: 10.1002/pro.3990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3990</ArticleId><ArticleId IdType="pmc">PMC7784771</ArticleId><ArticleId IdType="pubmed">33151007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs G.G., Murrell J.R., Horvath S., Haraszti L., Majtenyi K., Molnar M.J., Budka H., Ghetti B., Spina S. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov. Disord. 2009;24:1843&#x2013;1847. doi: 10.1002/mds.22697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22697</ArticleId><ArticleId IdType="pubmed">19609911</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno F., Rabinovici G.D., Karydas A., Miller Z., Hsu S.C., Legati A., Fong J., Schonhaut D., Esselmann H., Watson C., et al. A novel mutation P112H in the TARDBP gene associated with frontotemporal lobar degeneration without motor neuron disease and abundant neuritic amyloid plaques. Acta Neuropathol. Commun. 2015;3:19. doi: 10.1186/s40478-015-0190-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0190-6</ArticleId><ArticleId IdType="pmc">PMC4382926</ArticleId><ArticleId IdType="pubmed">25853458</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt A., Herholz D., Fiesel F.C., Kaur K., Muller D., Karsten P., Weber S.S., Kahle P.J., Marquardt T., Schulz J.B. TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS ONE. 2010;5:e12247. doi: 10.1371/journal.pone.0012247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012247</ArticleId><ArticleId IdType="pmc">PMC2923622</ArticleId><ArticleId IdType="pubmed">20806063</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Lu S., Gasior K., Singh D., Vazquez-Sanchez S., Tapia O., Toprani D., Beccari M.S., Yates J.R., 3rd, Da Cruz S., et al. HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells. Science. 2021;371 doi: 10.1126/science.abb4309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb4309</ArticleId><ArticleId IdType="pubmed">33335017</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Zennaro E., Fallini C., Weber M., Sommacal A., Buratti E., Silani V., Ratti A. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 2009;111:1051&#x2013;1061. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M.Y., Markmiller S., Vu A.Q., Javaherian A., Dowdle W.E., Jolivet P., Bushway P.J., Castello N.A., Baral A., Chan M.Y., et al. Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD. Neuron. 2019;103:802&#x2013;819.e11. doi: 10.1016/j.neuron.2019.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.05.048</ArticleId><ArticleId IdType="pmc">PMC6728177</ArticleId><ArticleId IdType="pubmed">31272829</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores B.N., Li X., Malik A.M., Martinez J., Beg A.A., Barmada S.J. An Intramolecular Salt Bridge Linking TDP43 RNA Binding, Protein Stability, and TDP43-Dependent Neurodegeneration. Cell Rep. 2019;27:1133&#x2013;1150.e8. doi: 10.1016/j.celrep.2019.03.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.03.093</ArticleId><ArticleId IdType="pmc">PMC6499398</ArticleId><ArticleId IdType="pubmed">31018129</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.R., King O.D., Shorter J., Gitler A.D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 2013;201:361&#x2013;372. doi: 10.1083/jcb.201302044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L., Bilgutay A., Zhang Y.J., Vanderweyde T., Citro A., Mehta T., Zaarur N., McKee A., Bowser R., Sherman M., et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: Analysis of cultured cells and pathological brain tissue. PLoS ONE. 2010;5:e13250. doi: 10.1371/journal.pone.0013250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013250</ArticleId><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentmann E., Neumann M., Tahirovic S., Rodde R., Dormann D., Haass C. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43) J. Biol. Chem. 2012;287:23079&#x2013;23094. doi: 10.1074/jbc.M111.328757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.328757</ArticleId><ArticleId IdType="pmc">PMC3391091</ArticleId><ArticleId IdType="pubmed">22563080</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkening K., Leystra-Lantz C., Yang W., Jaffee H., Strong M.J. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS) Brain Res. 2009;1305:168&#x2013;182. doi: 10.1016/j.brainres.2009.09.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.09.105</ArticleId><ArticleId IdType="pubmed">19815002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Cohen T.J. Aggregation of the nucleic acid-binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation. J. Biol. Chem. 2019;294:3696&#x2013;3706. doi: 10.1074/jbc.RA118.006351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.006351</ArticleId><ArticleId IdType="pmc">PMC6416430</ArticleId><ArticleId IdType="pubmed">30630951</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahboubi H., Stochaj U. Cytoplasmic stress granules: Dynamic modulators of cell signaling and disease. Biochim. Biophys. Acta Mol. Basis Dis. 2017;1863:884&#x2013;895. doi: 10.1016/j.bbadis.2016.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.12.022</ArticleId><ArticleId IdType="pubmed">28095315</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Gumina V., Lenzi P., Bossolasco P., Fulceri F., Volpe C., Bardelli D., Pregnolato F., Maraschi A., Fornai F., et al. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons. Neurobiol. Dis. 2020;145:105051. doi: 10.1016/j.nbd.2020.105051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105051</ArticleId><ArticleId IdType="pubmed">32827688</ArticleId></ArticleIdList></Reference><Reference><Citation>Orru S., Coni P., Floris A., Littera R., Carcassi C., Sogos V., Brancia C. Reduced stress granule formation and cell death in fibroblasts with the A382T mutation of TARDBP gene: Evidence for loss of TDP-43 nuclear function. Hum. Mol. Genet. 2016;25:4473&#x2013;4483. doi: 10.1093/hmg/ddw276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw276</ArticleId><ArticleId IdType="pubmed">28172957</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano N., Catalani A., Lattante S., Belardo A., Proietti S., Bertini L., Silvestri F., Catalani E., Cervia D., Zolla L., et al. ALS skin fibroblasts reveal oxidative stress and ERK1/2-mediated cytoplasmic localization of TDP-43. Cell Signal. 2020;70:109591. doi: 10.1016/j.cellsig.2020.109591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2020.109591</ArticleId><ArticleId IdType="pubmed">32126264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabuta C., Kono K., Wada K., Kabuta T. 4-Hydroxynonenal induces persistent insolubilization of TDP-43 and alters its intracellular localization. Biochem. Biophys. Res. Commun. 2015;463:82&#x2013;87. doi: 10.1016/j.bbrc.2015.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.05.027</ArticleId><ArticleId IdType="pubmed">25998392</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L., Gomes E., Guo L., Mojsilovic-Petrovic J., Tran V., Kalb R.G., Shorter J., Bonini N.M. Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization. Mol. Cell. 2018;71:703&#x2013;717.e9. doi: 10.1016/j.molcel.2018.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerowitz J., Parker S.J., Vella L.J., Ng D., Price K.A., Liddell J.R., Caragounis A., Li Q.X., Masters C.L., Nonaka T., et al. C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Mol. Neurodegener. 2011;6:57. doi: 10.1186/1750-1326-6-57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-57</ArticleId><ArticleId IdType="pmc">PMC3162576</ArticleId><ArticleId IdType="pubmed">21819629</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker S.J., Meyerowitz J., James J.L., Liddell J.R., Nonaka T., Hasegawa M., Kanninen K.M., Lim S., Paterson B.M., Donnelly P.S., et al. Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes. PLoS ONE. 2012;7:e42277. doi: 10.1371/journal.pone.0042277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0042277</ArticleId><ArticleId IdType="pmc">PMC3411774</ArticleId><ArticleId IdType="pubmed">22879928</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker S.J., Meyerowitz J., James J.L., Liddell J.R., Crouch P.J., Kanninen K.M., White A.R. Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates. Neurochem. Int. 2012;60:415&#x2013;424. doi: 10.1016/j.neuint.2012.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2012.01.019</ArticleId><ArticleId IdType="pubmed">22306778</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D., James J.L., Parker S.J., Lidgerwood G.E., Duncan C., Meyerowitz J., Nonaka T., Hasegawa M., Kanninen K.M., Grubman A., et al. Kinase Inhibitor Screening Identifies Cyclin-Dependent Kinases and Glycogen Synthase Kinase 3 as Potential Modulators of TDP-43 Cytosolic Accumulation during Cell Stress. PLoS ONE. 2013;8:e67433. doi: 10.1371/journal.pone.0067433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067433</ArticleId><ArticleId IdType="pmc">PMC3694067</ArticleId><ArticleId IdType="pubmed">23840699</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.K., Soo K.Y., Sundaramoorthy V., Parakh S., Ma Y., Farg M.A., Wallace R.H., Crouch P.J., Turner B.J., Horne M.K., et al. ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation. PLoS ONE. 2013;8:e81170. doi: 10.1371/journal.pone.0081170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081170</ArticleId><ArticleId IdType="pmc">PMC3843686</ArticleId><ArticleId IdType="pubmed">24312274</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashi S., Kabuta T., Nagai Y., Tsuchiya Y., Akiyama H., Wada K. TDP-43 associates with stalled ribosomes and contributes to cell survival during cellular stress. J. Neurochem. 2013;126:288&#x2013;300. doi: 10.1111/jnc.12194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12194</ArticleId><ArticleId IdType="pubmed">23398327</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Nicholson A.M., Sarkar M., Messing J., Purice M.D., Pottier C., Annu K., Baker M., Perkerson R.B., Kurti A., et al. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron. 2017;95:808&#x2013;816.e9. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald K.K., Aulas A., Destroismaisons L., Pickles S., Beleac E., Camu W., Rouleau G.A., Vande Velde C. TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum. Mol. Genet. 2011;20:1400&#x2013;1410. doi: 10.1093/hmg/ddr021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr021</ArticleId><ArticleId IdType="pubmed">21257637</ArticleId></ArticleIdList></Reference><Reference><Citation>Besnard-Guerin C. Cytoplasmic localization of amyotrophic lateral sclerosis-related TDP-43 proteins modulates stress granule formation. Eur. J. Neurosci. 2020;52:3995&#x2013;4008. doi: 10.1111/ejn.14762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.14762</ArticleId><ArticleId IdType="pubmed">32343854</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey C.M., Cenik B., Sephton C.F., Dries D.R., Mayer P., 3rd, Good S.K., Johnson B.A., Herz J., Yu G. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol. Cell Biol. 2011;31:1098&#x2013;1108. doi: 10.1128/MCB.01279-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01279-10</ArticleId><ArticleId IdType="pmc">PMC3067820</ArticleId><ArticleId IdType="pubmed">21173160</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans F., Glasebach H., Kahle P.J. Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules. J. Biol. Chem. 2020;295:673&#x2013;689. doi: 10.1016/S0021-9258(17)49926-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)49926-1</ArticleId><ArticleId IdType="pmc">PMC6970928</ArticleId><ArticleId IdType="pubmed">31780563</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler M.S., Strobel B., Freischmidt A., Helferich A.M., Kappel J., Brewer B.M., Li D., Thal D.R., Walther P., Ludolph A.C., et al. TDP-43 is intercellularly transmitted across axon terminals. J. Cell Biol. 2015;211:897&#x2013;911. doi: 10.1083/jcb.201504057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H.Y., Hou S.C., Way T.D., Wong C.H., Wang I.F. Heat-shock protein dysregulation is associated with functional and pathological TDP-43 aggregation. Nat. Commun. 2013;4:2757. doi: 10.1038/ncomms3757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms3757</ArticleId><ArticleId IdType="pubmed">24220679</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Maxwell B.A., Joo J.H., Gwon Y., Messing J., Mishra A., Shaw T.I., Ward A.L., Quan H., Sakurada S.M., et al. ULK1 and ULK2 Regulate Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97. Mol. Cell. 2019;74:742&#x2013;757.e8. doi: 10.1016/j.molcel.2019.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.03.027</ArticleId><ArticleId IdType="pmc">PMC6859904</ArticleId><ArticleId IdType="pubmed">30979586</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Fan B., Yang P., Temirov J., Messing J., Kim H.J., Taylor J.P. Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology. eLife. 2019;8 doi: 10.7554/eLife.39578.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.39578</ArticleId><ArticleId IdType="pmc">PMC6426440</ArticleId><ArticleId IdType="pubmed">30893049</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes N., Nero L., Lyons S.M., Ivanov P., Mittelmeier T.M., Bolger T.A., Buchan J.R. Stress Granule Assembly Can Facilitate but Is Not Required for TDP-43 Cytoplasmic Aggregation. Biomolecules. 2020;10:1367. doi: 10.3390/biom10101367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10101367</ArticleId><ArticleId IdType="pmc">PMC7650667</ArticleId><ArticleId IdType="pubmed">32992901</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D., James J.L., Yang S., Zhang K., Duncan C., Moujalled D.M., Parker S.J., Caragounis A., Lidgerwood G., Turner B.J., et al. Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43. Hum. Mol. Genet. 2015;24:1655&#x2013;1669. doi: 10.1093/hmg/ddu578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu578</ArticleId><ArticleId IdType="pubmed">25410660</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T., Hock E.M., Ernst P., Foglieni C., Jambeau M., Gilhespy L.A.B., Laferriere F., Maniecka Z., Pluckthun A., Mittl P., et al. Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun. 2017;8:45. doi: 10.1038/s41467-017-00062-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00062-0</ArticleId><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalfallah Y., Kuta R., Grasmuck C., Prat A., Durham H.D., Vande Velde C. TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci. Rep. 2018;8:7551. doi: 10.1038/s41598-018-25767-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25767-0</ArticleId><ArticleId IdType="pmc">PMC5953947</ArticleId><ArticleId IdType="pubmed">29765078</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Nonoka T., Kametani F., Yamashita M., Hosokawa M., Niizato K., Tsuchiya K., Kobayashi Z., Ikeda K., et al. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology. 2010;30:170&#x2013;181. doi: 10.1111/j.1440-1789.2009.01089.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2009.01089.x</ArticleId><ArticleId IdType="pubmed">20102522</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson E.N., Gochenaur L., Singh A., Grant R., Patel K., Watkins S., Wu J.Y., Pandey U.B. Traumatic injury induces stress granule formation and enhances motor dysfunctions in ALS/FTD models. Hum. Mol. Genet. 2018;27:1366&#x2013;1381. doi: 10.1093/hmg/ddy047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy047</ArticleId><ArticleId IdType="pmc">PMC6455923</ArticleId><ArticleId IdType="pubmed">29432563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiesner D., Tar L., Linkus B., Chandrasekar A., Olde Heuvel F., Dupuis L., Tsao W., Wong P.C., Ludolph A., Roselli F. Reversible induction of TDP-43 granules in cortical neurons after traumatic injury. Exp. Neurol. 2018;299:15&#x2013;25. doi: 10.1016/j.expneurol.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.09.011</ArticleId><ArticleId IdType="pubmed">28941811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J.M., La Spada A.R. ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration. Neurology. 2009;73:805&#x2013;811. doi: 10.1212/WNL.0b013e3181b6bbbd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b6bbbd</ArticleId><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Arai K., Del Tredici K., Toledo J.B., Robinson J.L., Lee E.B., Kuwabara S., Shibuya K., Irwin D.J., Fang L., et al. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 2014;128:423&#x2013;437. doi: 10.1007/s00401-014-1299-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1299-6</ArticleId><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y.S., Tsai K.J., Chang Y.J., Kao P., Woods R., Kuo P.H., Wu C.C., Liao J.Y., Chou S.C., Lin V., et al. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients. Nat. Commun. 2014;5:4824. doi: 10.1038/ncomms5824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5824</ArticleId><ArticleId IdType="pubmed">25215604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A., Yuno S., Muto H., Kinjo M. Different aggregation states of a nuclear localization signal-tagged 25-kDa C-terminal fragment of TAR RNA/DNA-binding protein 43 kDa. Genes Cells. 2017;22:521&#x2013;534. doi: 10.1111/gtc.12495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12495</ArticleId><ArticleId IdType="pubmed">28497562</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.S., Snead D., Lee J.J., McCaffery J.M., Shorter J., Gitler A.D. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 2009;284:20329&#x2013;20339. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., Kaneko K., Watanabe S., Yamanaka K., Nukina N. A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J. Biol. Chem. 2011;286:18664&#x2013;18672. doi: 10.1074/jbc.M111.231209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.231209</ArticleId><ArticleId IdType="pmc">PMC3099683</ArticleId><ArticleId IdType="pubmed">21454603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao P.F., Chen Y.R., Liu X.B., DeCarli C., Seeley W.W., Jin L.W. Detection of TDP-43 oligomers in frontotemporal lobar degeneration-TDP. Ann. Neurol. 2015;78:211&#x2013;221. doi: 10.1002/ana.24431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24431</ArticleId><ArticleId IdType="pmc">PMC4822421</ArticleId><ArticleId IdType="pubmed">25921485</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X., Xiang Z., Qin C., Chen Y., Tian H., Meng L., Xia D., Liu H., Song J., Fu J., et al. Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice. Acta Neuropathol. Commun. 2021;9:15. doi: 10.1186/s40478-020-01112-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01112-3</ArticleId><ArticleId IdType="pmc">PMC7814549</ArticleId><ArticleId IdType="pubmed">33461623</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P., Risse E., Tyzack G.E., Mitchell J.S., Taha D.M., Chen Y.R., Newcombe J., Collinge J., Sidle K., Patani R. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis. Brain. 2020;143:430&#x2013;440. doi: 10.1093/brain/awz419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz419</ArticleId><ArticleId IdType="pmc">PMC7009461</ArticleId><ArticleId IdType="pubmed">32040555</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimonaka S., Nonaka T., Suzuki G., Hisanaga S., Hasegawa M. Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils. J. Biol Chem. 2016;291:8896&#x2013;8907. doi: 10.1074/jbc.M115.713552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.713552</ArticleId><ArticleId IdType="pmc">PMC4861459</ArticleId><ArticleId IdType="pubmed">26887947</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P., Newcombe J., Troakes C., Simone R., Chen Y.R., Patani R., Sidle K. In vitro prion-like behaviour of TDP-43 in ALS. Neurobiol. Dis. 2016;96:236&#x2013;247. doi: 10.1016/j.nbd.2016.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.08.007</ArticleId><ArticleId IdType="pmc">PMC5113659</ArticleId><ArticleId IdType="pubmed">27590623</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeineddine R., Whiten D.R., Farrawell N.E., McAlary L., Hanspal M.A., Kumita J.R., Wilson M.R., Yerbury J.J. Flow cytometric measurement of the cellular propagation of TDP-43 aggregation. Prion. 2017;11:195&#x2013;204. doi: 10.1080/19336896.2017.1314426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2017.1314426</ArticleId><ArticleId IdType="pmc">PMC5480386</ArticleId><ArticleId IdType="pubmed">28486039</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii T., Kawakami E., Endo K., Misawa H., Watabe K. Formation and spreading of TDP-43 aggregates in cultured neuronal and glial cells demonstrated by time-lapse imaging. PLoS ONE. 2017;12:e0179375. doi: 10.1371/journal.pone.0179375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179375</ArticleId><ArticleId IdType="pmc">PMC5466347</ArticleId><ArticleId IdType="pubmed">28599005</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T., Masuda-Suzukake M., Arai T., Hasegawa Y., Akatsu H., Obi T., Yoshida M., Murayama S., Mann D.M., Akiyama H., et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013;4:124&#x2013;134. doi: 10.1016/j.celrep.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y., Eid L., Parent M., Soucy G., Bareil C., Riku Y., Kawai K., Takagi S., Yoshida M., Katsuno M., et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 2016;139:3187&#x2013;3201. doi: 10.1093/brain/aww237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww237</ArticleId><ArticleId IdType="pmc">PMC5840881</ArticleId><ArticleId IdType="pubmed">27679482</ArticleId></ArticleIdList></Reference><Reference><Citation>Peled S., Sade D., Bram Y., Porat Z., Kreiser T., Mimouni M., Lichtenstein A., Segal D., Gazit E. Single cell imaging and quantification of TDP-43 and alpha-synuclein intercellular propagation. Sci. Rep. 2017;7:544. doi: 10.1038/s41598-017-00657-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00657-z</ArticleId><ArticleId IdType="pmc">PMC5428807</ArticleId><ArticleId IdType="pubmed">28373710</ArticleId></ArticleIdList></Reference><Reference><Citation>Sackmann C., Sackmann V., Hallbeck M. TDP-43 Is Efficiently Transferred Between Neuron-Like Cells in a Manner Enhanced by Preservation of Its N-Terminus but Independent of Extracellular Vesicles. Front. Neurosci. 2020;14:540. doi: 10.3389/fnins.2020.00540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00540</ArticleId><ArticleId IdType="pmc">PMC7301158</ArticleId><ArticleId IdType="pubmed">32595443</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S., Xu Y., Restrepo C.R., Kwong L.K., Zhang B., Brown H.J., Lee E.B., Trojanowski J.Q., Lee V.M. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat. Commun. 2018;9:4220. doi: 10.1038/s41467-018-06548-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06548-9</ArticleId><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Calvo A., Chio A., Colville S., Ellis C.M., Hardiman O., Heverin M., Howard R.S., Huisman M.H.B., Keren N., et al. Analysis of amyotrophic lateral sclerosis as a multistep process: A population-based modelling study. Lancet Neurol. 2014;13:1108&#x2013;1113. doi: 10.1016/S1474-4422(14)70219-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E., Grad L.I., Cashman N.R. TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion. Sci. Rep. 2016;6:22155. doi: 10.1038/srep22155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep22155</ArticleId><ArticleId IdType="pmc">PMC4772009</ArticleId><ArticleId IdType="pubmed">26926802</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer R., Lanznaster D., Bourgeais J., Herault O., Vourc&#x2019;h P., Andres C.R., Corcia P., Blasco H. Conditioned Medium from Cells Overexpressing TDP-43 Alters the Metabolome of Recipient Cells. Cells. 2020;9:2198. doi: 10.3390/cells9102198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9102198</ArticleId><ArticleId IdType="pmc">PMC7601466</ArticleId><ArticleId IdType="pubmed">33003404</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan K., Murphy J., Singh A., Mitchell C.S. Astrocyte-Mediated Neuromodulatory Regulation in Preclinical ALS: A Metadata Analysis. Front. Cell Neurosci. 2018;12:491. doi: 10.3389/fncel.2018.00491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00491</ArticleId><ArticleId IdType="pmc">PMC6305074</ArticleId><ArticleId IdType="pubmed">30618638</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Meyer K., Sherwood T.W., Vick J., Likhite S., Frakes A., Miranda C.J., Braun L., Heath P.R., Pineda R., et al. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc. Natl. Acad. Sci. USA. 2016;113:E6496&#x2013;E6505. doi: 10.1073/pnas.1607496113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607496113</ArticleId><ArticleId IdType="pmc">PMC5081600</ArticleId><ArticleId IdType="pubmed">27688759</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Le W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol. Neurobiol. 2016;53:1181&#x2013;1194. doi: 10.1007/s12035-014-9070-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-9070-5</ArticleId><ArticleId IdType="pubmed">25598354</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller K.J., Restrepo C.R., Khan T., Dominique M.A., Fang T.C., Canter R.G., Roberts C.J., Miller K.R., Ransohoff R.M., Trojanowski J.Q., et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 2018;21:329&#x2013;340. doi: 10.1038/s41593-018-0083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Svahn A.J., Don E.K., Badrock A.P., Cole N.J., Graeber M.B., Yerbury J.J., Chung R., Morsch M. Nucleo-cytoplasmic transport of TDP-43 studied in real time: Impaired microglia function leads to axonal spreading of TDP-43 in degenerating motor neurons. Acta Neuropathol. 2018;136:445&#x2013;459. doi: 10.1007/s00401-018-1875-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1875-2</ArticleId><ArticleId IdType="pmc">PMC6096729</ArticleId><ArticleId IdType="pubmed">29943193</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima M., Tan R., Halliday G.M., Kril J.J. Spread of pathology in amyotrophic lateral sclerosis: Assessment of phosphorylated TDP-43 along axonal pathways. Acta Neuropathol. Commun. 2015;3:47. doi: 10.1186/s40478-015-0226-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0226-y</ArticleId><ArticleId IdType="pmc">PMC4517552</ArticleId><ArticleId IdType="pubmed">26216351</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente Pons A., Higginbottom A., Cooper-Knock J., Alrafiah A., Alofi E., Kirby J., Shaw P.J., Wood J.D., Highley J.R. Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis. J. Pathol. 2020;251:262&#x2013;271. doi: 10.1002/path.5455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5455</ArticleId><ArticleId IdType="pubmed">32391572</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>